Literature DB >> 25148728

Routine application of Raman spectroscopy in the quality control of hospital compounded ganciclovir.

Alexandre Amin1, Philippe Bourget2, Fabrice Vidal3, Flavie Ader3.   

Abstract

This study compares the performance of a reference method of HPLC to Raman spectroscopy (RS) for the analytical quality control (AQC) of therapeutic objects. We assessed a model consisting of a widely used antiviral drug, i.e., ganciclovir, which was compounded in a medical device and then transferred in a vacuum glass vial prior to analyses. As the aim of the alternative RS method is to replace the destructive, time-consuming HPLC method, requiring sample preparation, it needs to be demonstrated that RS performs at least as good as the HPLC method. Therefore, the two methods were validated by calculating the accuracy profile and provided excellent results for the analytical validation key criteria, i.e., trueness, precision and accuracy, ranging from 0.8 to 10mg/mL. The Spearman and Kendall correlation tests (p-value<1.10-15) and the statistical studies performed on the graphs confirm a strong correlation in the results between RS and the standard HPLC under the experimental conditions. These results confirmed the potential of this option for future applications, owing to its analytical and practical quality and its contributions to the safety of the medication circuit. This method also greatly contributes to the protection of caregivers and their working environment.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Analytical quality control; Ganciclovir; Ganciclovir (PubChem CID: 3454); HPLC; Hospital environment; Raman spectroscopy; Safety

Mesh:

Substances:

Year:  2014        PMID: 25148728     DOI: 10.1016/j.ijpharm.2014.08.028

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  1 in total

1.  Discriminative and Quantitative Analysis of Antineoplastic Taxane Drugs Using a Handheld Raman Spectrometer.

Authors:  Laetitia Lê; Marion Berge; Ali Tfayli; Patrice Prognon; Eric Caudron
Journal:  Biomed Res Int       Date:  2018-07-03       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.